Mirae Asset Global Investments Co., Ltd. Arvinas, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Arvinas, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,043 shares of ARVN stock, worth $50,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,043
Previous 23,478
91.3%
Holding current value
$50,012
Previous $969,000
94.43%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ARVN
# of Institutions
224Shares Held
68.6MCall Options Held
166KPut Options Held
31.3K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$165 Million6.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.67MShares$163 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$153 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.99MShares$97.6 Million0.01% of portfolio
-
Avidity Partners Management LP Dallas, TX2.99MShares$73.1 Million3.91% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.3B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...